How to promote early HIV testing;Cómo promover y facilitar el diagnóstico precoz de la infección por el VIH-1

Enfermedades Emergentes

Volumn 12, Issue 2, 2010, Pages 121-124

  Gatell, Jose M ^a   Zulaica, Daniel ^b   Del Romero, Jorge ^c,d   Robledo, Teresa ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Sociedad Española Interdisciplinar del Sida ^*  (Spain)

^c CENTRO SANITARIO SANDOVAL   (Spain)

^d Fundacion para la Formacion e Informacion Sobre Tratamientos Frente al VIH Sida (FIT)   (Spain)

Author keywords

AIDS; Early diagnosis; HIV in Spain

Indexed keywords

ARTICLE; EARLY DIAGNOSIS; HEALTH CARE POLICY; HEALTH PROMOTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIFE EXPECTANCY; MASS SCREENING; MORTALITY; SPAIN;

EID: 84455174844     PISSN: 15754723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Masur M, Michelis MA, Greene JB. An outbreak of community-adquired Peumocystis carinii pneumonia. N Engl J Med 1981;305:1431-8.
2. Masur H, Michelis DF, Wormser GP, Lewin SJ, Gold J, Tapper ML, et al. Opportunistic infection in previously healthy women. Ann Intern Med 1982;97:533-9.
3. Bindels P, Reijneveld SA, Mulder D, Coutinho RA, Van den HA. Impact of AIDS on premature mortality in Amsterdam, 1982-1992. AIDS 1994;8:233-7. (Pubitemid 24094120)
4. May RM, Anderson RM. Transmission dynamics of HIV infection. Nature 1987;326:137- 42.
5. Johnson AM, Laga M. Heterosexual transmission of HIV. AIDS 1988;2(suppl 1):S49- S56.
6. Consensus statements on HIV transmission. Lancet 1989;1:396.
7. Cooper DA, MacLean P, Finlayson R, Michelmore HM, Gold J, Donovan B, et al. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1985;1:537-40. (Pubitemid 15101846)
8. Miro JM, Buira E, Mallolas J, Gallart T, Moreno A, Zamora L, et al. Linfocitos CD4 e infecciones oportunistas y neoplasias en pacientes con infeccion por el virus de la inmunodeficiencia humana. Med Clin (Barc) 1994;102:566-70.
9. Batalla J, Gatell JM, Cayla JA, Plasencia A, Jansa JM, Parellada N. Predictors of the Survival of Aids Cases in Barcelona, Spain. AIDS 1989;3:355-9. (Pubitemid 19184093)
10. Buira E, Gatell JM, Miro JM, Batalla J, Zamora L, Mallolas J, et al. Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients. J Acquir Immune Defic Syndr 1992;5:737-42.
11. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60. (Pubitemid 28135961)
12. Martinez E, Milinkovic A, Buira E, De Lazzari E, Leon A, Larrousse M, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Medicine. 2007;8:251-8. (Pubitemid 46695372)
13. Arribas JR, Pozniak AL, Gallant JE, DeJesus E, Gazzard B, Campo RE, et al. Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients: 144- Week Analysis. J Acquir Immune Defic Syndr 2008;47:74-8. (Pubitemid 351619372)
14. Battegay M, Fehr J, Fluckiger U, Elzi L. Antiretroviral therapy of late presenters with advanced HIV disease. J Antimicrob Chemother 2008;62(1):41-4. (Pubitemid 351865872)
15. Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, Phillips AN, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 2004;18:2145-51. (Pubitemid 39463679)
16. Marks G, Crepaz N, Janssen RS. Estimated sexual transmission of HIV from persons aware and unaware that thye are infected with the virus in the USA. AIDS 2006;20:1447-50. (Pubitemid 43948252)
17. Holtgrave DR. CDC recommendations for opt-out HIV testing. JAMA 2009;301: 274-6.
18. Corey L. CDC recommendations for opt-out HIV testing. JAMA 2009;301:274-5.
19. Bartlett JG, Mayer KH. Routine opt-out HIV testing: rationale for the consensus conference and this supplement. Clin Infect Dis 2007;45:S203-S205. (Pubitemid 351417217)
20. Branson BM, Handsfield HH, Lampe MA, JANSSEN RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Re. 2006;55:1-17.
21. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 50(RR-19),1-57. 2001.
22. Centers for Disease Control and Prevention. Revised recommendations for HIV of adults adolescents and pregnant women in helath care settings. MMWR 2006;50:1-16.
23. Gazzard B, Clumeck N, d'Arminio MA, Lundgren JD. Indicator disease-guided testing for HIV-the next step for Europe? HIV Med 2008;9 Suppl 2:34-40. (Pubitemid 351819095)